Power Law company profile

SpringWorks Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2017 · IPO 2019 Unicorn

Clinical-stage biopharmaceutical company that identifies and advances promising science and pioneers efficient pathways

Valuation

$3.26B

Market cap · 2026

Revenue

$192M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

12 investors on SpringWorks Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

OrbiMed

LifeArc

Pfizer

Bain Capital

Series B+ 8 investors entered at this stage

Perceptive Advisors

ArrowMark Partners

Samsara BioCapital

Deerfield

EcoR1 Capital

Invus

GSK

Boxer Capital

Global footprint

Where SpringWorks Therapeutics has talent and traffic

AI talent share

0.3% of workforce is AI talent
(1 of 400 staff)

Core AI00%

Other AI10.25%

Non-AI workforce39999.75%

Workforce by country

5 countries with
team presence

🇺🇸 United States96.8%

🇩🇪 Germany2.4%

🇨🇭 Switzerland0.8%

🇬🇧 United Kingdom0.6%

🇪🇸 Spain0.3%

5 countries shown

Web traffic by country

9.2K monthly visits
across markets

🇺🇸 United States77.2%

🇮🇳 India18.5%

🇩🇪 Germany4.3%

Top 3 markets shown

Patent intelligence

$23M patent portfolio · 60 active families

Estimated portfolio value

$23M

0.71% of market cap · 4.8× smaller than top peer Bavarian Nordic ($111M)

60 active patent families

Where SpringWorks Therapeutics innovates CarcinosisPharmacologyOncologyPharmaceutical medicineInternal medicine

Where SpringWorks Therapeutics concentrates vs peers

Each axis is a top-10 topic across SpringWorks Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about SpringWorks Therapeutics

An AI-synthesized read of the highest-engagement posts about SpringWorks Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SpringWorks Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles